Ashok Choudhury
Ashok Choudhury is an expert in Hepatology at Institute of Liver and Biliary Sciences (India). As of October 2026, ScienceLeadR ranks Ashok Choudhury in the top 1% of experts worldwide for Liver Failure and Hepatic Insufficiency. Ashok Choudhury has authored 170 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 800 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Public Health - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2011 - 2026
Number : 170
Citations
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The Global ACLF Consensus : the 'Istanbul Document'. PMID 42782569 — liver diseases, acute-on-chronic liver failure, liver, liver failure | Hepatol Int | 2026 | 0 |
| Portal vein thrombosis increases short-term mortality among hospitalized patients with cirrhosis in a global cohort. PMID 42766768 — liver transplantation, mortality, non-alcoholic fatty liver disease, portal vein, thrombosis, veins, hepatitis | Liver Transpl | 2026 | 0 |
| Harmonizing ACLF definition: Why is it essential for scientific progress? PMID 42660237 — liver diseases, liver | J Hepatol Top journal | 2026 | 0 |
| Duration of vasoconstrictors after endoscopic variceal ligation in acute variceal bleeding: A systematic review and network meta-analysis. PMID 42602141 — terlipressin, mortality, hemorrhage, endoscopy, network meta-analysis, ligation, varicose veins, octreotide, vasoconstrictor agents | Hepatol Forum | 2026 | 0 |
| A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper. PMID 42533257 — liver diseases, acute-on-chronic liver failure, multiple chronic conditions, critical care, liver, therapeutics, liver failure | Hepatol Int | 2026 | 1 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis NCT07299110 — whey proteins, blood, amino acids, ovum, ethanol, whey | N/A | Recruiting | 2025 |
| Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors NCT06549673 — research design, hypertension, safety, fibrosis, hepatitis, chronic, liver, esophageal and gastric varices, endoscopy, hypertension, portal, varicose veins, hepatitis | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map